Parker RI - Search Results

1

Effect of platelet count on the DDAVP-induced shortening of the bleeding time in thrombocytopenic Gaucher's patients.

Parker RI, Grewal RP, McKeown LP, Barton NW. Parker RI, et al. Am J Pediatr Hematol Oncol. 1992 Spring;14(1):39-43. doi: 10.1097/00043426-199221000-00005. Am J Pediatr Hematol Oncol. 1992. PMID: 1550261

2

Hematologic improvement in a patient with Gaucher disease on long-term enzyme replacement therapy: evidence for decreased splenic sequestration and improved red blood cell survival.

Parker RI, Barton NW, Read EJ, Brady RO. Parker RI, et al. Am J Hematol. 1991 Oct;38(2):130-7. doi: 10.1002/ajh.2830380211. Am J Hematol. 1991. PMID: 1951303

3

Absence of the largest platelet-von Willebrand multimers in a patient with lactoferrin deficiency and a bleeding tendency.

Parker RI, McKeown LP, Gallin JI, Gralnick HR. Parker RI, et al. Thromb Haemost. 1992 Mar 2;67(3):320-4. Thromb Haemost. 1992. PMID: 1641822

4

Dose-dependent responses to macrophage-targeted glucocerebrosidase in a child with Gaucher disease.

Barton NW, Brady RO, Dambrosia JM, Doppelt SH, Hill SC, Holder CA, Mankin HJ, Murray GJ, Zirzow GC, Parker RI. Barton NW, et al. Among authors: parker ri. J Pediatr. 1992 Feb;120(2 Pt 1):277-80. doi: 10.1016/s0022-3476(05)80444-5. J Pediatr. 1992. PMID: 1735829

5

Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease.

Barton NW, Brady RO, Dambrosia JM, Di Bisceglie AM, Doppelt SH, Hill SC, Mankin HJ, Murray GJ, Parker RI, Argoff CE, et al. Barton NW, et al. Among authors: parker ri. N Engl J Med. 1991 May 23;324(21):1464-70. doi: 10.1056/NEJM199105233242104. N Engl J Med. 1991. PMID: 2023606 Free article. Clinical Trial.

6

Platelet von Willebrand factor.

Gralnick HR, Williams SB, McKeown LP, Magruder L, Hansmann K, Vail M, Parker RI. Gralnick HR, et al. Among authors: parker ri. Mayo Clin Proc. 1991 Jun;66(6):634-40. doi: 10.1016/s0025-6196(12)60524-2. Mayo Clin Proc. 1991. PMID: 2046403 Review.

7

Failure to mobilize intracellular calcium in response to thrombin in a patient with familial thrombocytopathy characterized by macrothrombocytopenia and abnormal platelet membrane complexes.

Parker RI, Bray GL, McKeown LP, White JG. Parker RI, et al. J Lab Clin Med. 1993 Oct;122(4):441-9. J Lab Clin Med. 1993. PMID: 8228559

8

A human chimera for von Willebrand disease following bone marrow transplantation.

Ware RE, Parker RI, McKeown LP, Graham ML. Ware RE, et al. Among authors: parker ri. Am J Pediatr Hematol Oncol. 1993 Aug;15(3):338-42. Am J Pediatr Hematol Oncol. 1993. PMID: 8328650

9

Platelet von Willebrand factor: an important determinant of the bleeding time in type I von Willebrand's disease.

Gralnick HR, Rick ME, McKeown LP, Williams SB, Parker RI, Maisonneuve P, Jenneau C, Sultan Y. Gralnick HR, et al. Among authors: parker ri. Blood. 1986 Jul;68(1):58-61. Blood. 1986. PMID: 3487361 Free article.

10

Liver biopsies in patients with lysosomal storage disease: experience with effective sedation.

Grewal RP, Yu KT, Barton NW, Parker RI, Bisceglie AM. Grewal RP, et al. Among authors: parker ri. Indian J Pediatr. 1997 Nov-Dec;64(6):887-91. doi: 10.1007/BF02725518. Indian J Pediatr. 1997. PMID: 10771935 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

140 results

Search Page

Filters